Sponsored by:

Nuclear Medicine: Page 370

Cervical tumor volumes on FDG-PET predict treatment outcome
By Shalmali Pal
FDG-PET offers an accurate way to assess cervical tumor volumes post-treatment, but the prognosis is particularly grim for patients who exhibit residual disease on PET scans after brachytherapy, according to radiation oncologists from the Mallinckrodt Institute of Radiology in St. Louis.
July 13, 2005
2005 07 13 16 02 26 706
Lung PET rules when CT is equivocal, discordant
By Eric Barnes
Although PET's high cost ensures that CT and radiography will remain the first-line lung cancer detection modalities for at least the near future, PET can be very useful adjunctively in patients whose diagnosis remains uncertain in the light of available radiographic and clinical evidence.
July 11, 2005
GE, Roche join forces
By AuntMinnie.com staff writers
GE Healthcare and Swiss healthcare firm Roche are teaming up to explore personalized medicine in patients with Alzheimer's disease.
July 10, 2005
SPECT/CT brightens nuclear medicine's prospects
By Brian Casey
July 6, 2005
Can SPECT/CT revitalize nuclear medicine?
By Marvin Burns
SPECT/CT has been introduced recently with the expectation that it will emulate PET/CT's success as a hybrid imaging modality. Proponents are confident that the addition of CT will provide a new springboard for SPECT in nuclear cardiology as well as other functional studies, revitalizing traditional nuclear medicine.
July 6, 2005
2002 03 13 15 53 59 706
Report projects rapid PET procedure growth
By AuntMinnie.com staff writers
The demand for PET continued to grow in 2004, reaching 1 million procedures, an increase of 46% for the year. Procedure volume is expected to rise to 3.2 million procedures by 2010, according to a recent study by market research firm Bio-Tech Systems.
July 5, 2005
PET/CT provides cost-savings for NSCLC radiotherapy
By Jonathan S. Batchelor
PET/CT technology has been demonstrating superior diagnostic and staging capabilities for various malignancies in scientific studies. But the technology comes at a steep price point, and models for its economic efficiencies are still being created. However, researchers from Canada have found PET/CT to be cost-effective in radiation therapy planning for non-small cell lung cancer (NSCLC).
July 3, 2005
PET/CT improves diagnostic accuracy of unexpected malignancies
By N. Shivapriya
The use of PET/CT can decrease uncertainty and improve diagnostic accuracy in 18-F FDG-PET studies to detect unexpected malignancies, according to two recent studies in the Journal of Nuclear Medicine.
June 29, 2005
Radiopharmaceuticals market to reach $3.2 billion by 2010
By AuntMinnie.com staff writers
The overall U.S. market for diagnostic radiopharmaceuticals reached $1.53 billion in 2004 and is expected to rise to $3.2 billion by 2010, according to a recent study by market research firm Bio-Tech Systems.
June 28, 2005
Multiple modalities show similar results for initial staging of head and neck cancer
By Jonathan S. Batchelor
TORONTO - Head and neck cancer is the fifth most common cancer worldwide and accounts for 2.8% of all malignancies in the U.S., according to presentations this week at the Society of Nuclear Medicine (SNM) conference. Multimodality management of head and neck cancer patients is now the modus operandi in most medical centers.
June 22, 2005
Cedara inks molecular software deal
By AuntMinnie.com staff writers
Merge Healthcare's Cedara Software division has signed an agreement with Molecular Therapeutics of Ann Arbor, MI, to market and sell software for functional diffusion mapping.
June 21, 2005
Coronary PET links obesity to endothelial dysfunction, increased FDG uptake
By Jonathan S. Batchelor
TORONTO - Obesity is associated with abnormal coronary circulatory function and increases FDG uptake in large arteries, according to a pair of presentations at the Society of Nuclear Medicine (SNM) meeting this week.
June 21, 2005
Previous Page
Page 370 of 440
Next Page